Smith & Nephew, Inc.: Diabetic Foot trials

The registry lists 20 Diabetic Foot studies with Smith & Nephew, Inc. as lead sponsor. 0 are open to participants now and 12 have results posted.

Phase 3 1Phase 4 15No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Evaluation Of An Advanced Borderless DressingCompletedNCT03146845Not applicableResults posted
• Use of Santyl in Diabetic Foot UlcersCompletedNCT02581488Phase 4Results posted
• Single-Use Negative Pressure Wound Therapy System vs. Traditional Negative Pressure Wound Therapy System (tNPWT)CompletedNCT02470806Not applicableResults posted
• A RCT to Compare the Effects of Two Wound Products on Biofilm Disruption in DFUsTerminatedNCT02181621Not applicableResults posted
• Study of Oasis Ultra in Diabetic Foot UlcersCompletedNCT01835379Phase 4Results posted
• Using Santyl on Diabetic Foot UlcersCompletedNCT01408277Phase 4Results posted
• Wound Edge Changes Following Treatment With SantylCompletedNCT01197898Phase 4Results posted
• Enzymatic Versus (vs) Autolytic Debridement of Diabetic Foot UlcersCompletedNCT01143727Phase 4Results posted
• A Study to Look at the Effects of Four Weeks of Treatment on the Healing of Diabetic Foot UlcersCompletedNCT01143714Phase 4Results posted
• Santyl vs. Sharp Debridement of Diabetic Foot WoundsCompletedNCT01056198Phase 4Results posted
• Evaluation of the Effects of HP828-101 Versus Standard of Care in the Management of Partial or Full Thickness WoundsCompletedNCT00971048Not applicableResults posted
• OASIS Wound Matrix (Oasis) Mechanism of ActionCompletedNCT00570141Phase 4Results posted
• TruSkin®: Study for the Treatment of Chronic Diabetic Foot UlcersTerminatedNCT02936115Phase 4
• Use of Santyl Within an Accountable Care OrganizationWithdrawnNCT02716519Phase 4
• GrafixPRIME® for the Treatment of Chronic Diabetic Foot UlcersCompletedNCT02675855Phase 4
• Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot UlcersTerminatedNCT02571738Phase 3
• GrafixCORE®: Open-Label Study to Evaluate the Safety and Efficacy of GrafixCORE® for Complex Diabetic Foot WoundsCompletedNCT02260609Phase 4
• Santyl Applications to Diabetic Foot UlcersCompletedNCT02111291Phase 4
• Grafix® DFU: Open-Label Extension Option to Evaluate Safety & Efficacy of Grafix® for Chronic Diabetic Foot UlcersCompletedNCT01596920Phase 4
• Study Comparing VERSAJET With Conventional Surgical Procedures in the Removal of Unhealthy Tissue From Lower Limb UlcersCompletedNCT00521027Phase 4